1. Home
  2. POET vs BBOT Comparison

POET vs BBOT Comparison

Compare POET & BBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo POET Technologies Inc.

POET

POET Technologies Inc.

HOLD

Current Price

$6.85

Market Cap

959.0M

Sector

Technology

ML Signal

HOLD

Logo BridgeBio Oncology Therapeutics Inc.

BBOT

BridgeBio Oncology Therapeutics Inc.

N/A

Current Price

$9.14

Market Cap

1.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
POET
BBOT
Founded
1972
2016
Country
Canada
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
959.0M
1.1B
IPO Year
2008
N/A

Fundamental Metrics

Financial Performance
Metric
POET
BBOT
Price
$6.85
$9.14
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
$24.00
AVG Volume (30 Days)
6.2M
237.9K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$2,939.08
N/A
Revenue Next Year
$710.17
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.10
$8.70
52 Week High
$9.41
$14.87

Technical Indicators

Market Signals
Indicator
POET
BBOT
Relative Strength Index (RSI) 54.76 34.72
Support Level $6.88 $8.80
Resistance Level $7.42 $12.36
Average True Range (ATR) 0.61 0.57
MACD 0.12 -0.04
Stochastic Oscillator 48.31 12.39

Price Performance

Historical Comparison
POET
BBOT

About POET POET Technologies Inc.

POET Technologies Inc is a design and development company offering high-speed optical engines, light source products, and custom optical modules to the artificial intelligence systems market and hyperscale data centers. Its integration solutions are based on the POET Optical Interposer, a novel, patented platform that allows the seamless integration of electronic and photonic devices into a single chip using wafer-level semiconductor manufacturing techniques. POET's Optical Interposer platform also solves device integration challenges across a broad range of communication, computing, and sensing applications. The company operates geographically in the United States, Canada, Singapore and China.

About BBOT BridgeBio Oncology Therapeutics Inc.

BridgeBio Oncology Therapeutics Inc, formerly BridgeBio Oncology Therapeutics is a clinical-stage biotechnology company that aims to transform the lives of patients with cancers driven by RAS and PI3Ka, the two frequently mutated oncogenes.

Share on Social Networks: